|
Home > QR-E-Letter Archive > 4-14-2005
Issue No. 4 April 14, 2005
Welcome to the free Quick-Reference E-Letter from the publishers of The Complete Practitioner: Mental Health Applications. We hope you find the "Quick-Reference" items (below) interesting and helpful. (NOTE: We do not receive emails at the email address noted in the "From:" line of this email. To contact us, see the options toward the bottom of this page. Thank you.)
We will not disclose your email address to others. Among the reasons that you have received this e-letter are that you have requested it, and/or have subscribed to The Complete Practitioner (printed monthly), and/or you have expressed interest in The Complete Practitioner, and/or a colleague thought you would be interested in receiving this e-letter.
|
QUICK REFERENCE #8: How many 12- and 13-year-olds in the US have used inhalants?
“In 2002 and 2003, an annual average of 718,000 (8.6%) youths aged 12 or 13 had used an inhalant in their lifetime.”
“Youths aged 12 or 13 who used inhalants in their lifetime were more than twice as likely to have been in a serious fight at school or work during the past year than youths their age who had never used inhalants.”
“About 35% of youths aged 12 or 13 who used inhalants in their lifetime also used another illicit drug compared with 7.5% of youths aged 12 or 13 who had never used inhalants in their lifetime.”
SOURCE: The NSDUH* Report: Inhalant Use and Delinquent Behaviors among Young Adolescents.
http://www.oas.samhsa.gov/2k5/inhale/inhale.cfm
*The National Survey on Drug Use and Health (NSDUH) is an annual survey sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA).
QUICK REFERENCE #9: Categories of blood pressure are defined by what ranges of blood pressure?
The following Classification of Blood Pressure (BP) was presented in the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7).
Normal: less than 120* (systolic) AND less than 80 (diastolic)
Prehypertension: 120-139 (systolic) OR 80-89 (diastolic)
Hypertension, Stage 1: 140-159 systolic OR 90-99 (diastolic)
Hypertension, Stage 2: 160 or greater (systolic) OR 100 or greater (diastolic)
*in mmHg (millimeters of mercury)
A SUMMARY of JNC7 hypertension-related guidelines, including lifestyle modification recommendations, can be found on The Complete Practitioner: Mental Health Applications Web site.
http://www.completepractitioner.com/pages.shtml
|
CONTINUING EDUCATION (CE) COURSES
For information about online Continuing Education courses that enable you to print out your CE certificate immediately after passing an exam, click here [http://tcpceu.com]. (CE courses are available for purchase.)
THE COMPLETE PRACTITIONER: MENTAL HEALTH APPLICATIONS
For information about our print publication (The Complete Practitioner: Mental Health Applications), click here [http://www.completepractitioner.com]. (Subscriptions to The Complete Practitioner: Mental Health Applications are available for purchase.)
TO SEND THIS E-LETTER TO A COLLEAGUE
To forward this e-letter to a colleague, click here [http://www.completepractitioner.com/cgi-bin/refer.cgi].
TO REGISTER TO RECEIVE THE QR-E-LETTER
If you received this e-letter from a colleague, you can register to regularly receive this free e-letter (approximately every two weeks). To register to regularly receive this e-letter, click here [http://www.completepractitioner.com/cgi-bin/register.cgi].
TO CHANGE THE E-MAIL ADDRESS TO WHICH YOU WANT THE QR-E-LETTER SENT
To provide us with your changed email address click here [http://www.completepractitioner.com/cgi-bin/change.cgi].
TO STOP RECEIVING THE QR-E-LETTER (ie, to UNREGISTER)
To stop receiving the QR-E-Letter send a blank email to: leave-eletter@completepractitioner.com.
The QR-E-Letter can receive email at eletter@completepractitioner.com. (We do not receive emails at the email address that appears in the "From:" line of this email. Thank you.)
|
IMPORTANT: Inclusion of content in this e-letter is for educational purposes only and does not indicate endorsement of any claims or recommendations made or implied by that content or by the content of any Web sites that are noted in or linked to this e-letter.
| |
We hope that you have enjoyed receiving this e-letter. Please note that a small portion of this e-letter contains advertising (as indicated, for example, by text stating that an item is available for purchase).
| 